{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:33:41Z","timestamp":1791048821168,"version":"4.1.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1097\/mph.0000000000000241","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T11:17:50Z","timestamp":1409311070000},"page":"e135-e137","source":"Crossref","is-referenced-by-count":19,"title":["Severe Hemolytic Transfusion Reaction Due to Anti-D in a D+ Patient With Sickle Cell Disease"],"prefix":"10.1097","volume":"37","author":[{"given":"Tina S.","family":"Ipe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Wilkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge D.","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella T.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-29-20210209","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/pbc.24179","article-title":"Indications and complications of transfusions in sickle cell disease.","volume":"59","author":"Smith-Whitley","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R2-29-20210209","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":". High prevalence of red blood alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"key":"R3-29-20210209","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/pbc.24530","article-title":". Alloimmunization in sickle cell anemia in the era of extended red cell typing.","volume":"60","author":"OSuoji","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R4-29-20210209","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1537-2995.2012.03796.x","article-title":". Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.","volume":"53","author":"Miller","year":"2013","journal-title":"Transfusion"},{"key":"R5-29-20210209","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.3324\/haematol.2014.104703","article-title":". Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti Rh linked to partial Rh phenotype.","volume":"99","author":"Silvy","year":"2014","journal-title":"Haematologica"},{"key":"R6-29-20210209","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1423-0410.1980.tb02337.x","article-title":". Positive direct antiglobulin test in normal individuals.","volume":"38","author":"Gorst","year":"1980","journal-title":"Vox Sang"},{"key":"R7-29-20210209","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/ajh.23218","article-title":". The direct antiglobulin test: a critical step in the evaluation of hemolysis.","volume":"87","author":"Zantek","year":"2012","journal-title":"Am J Hematol"},{"key":"R8-29-20210209","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/ehm.09.2","article-title":"Hyperhemolysis syndrome in sickle cell disease.","volume":"2","author":"Win","year":"2009","journal-title":"Expert Rev Hematol"},{"key":"R9-29-20210209","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1537-2995.2010.03045.x","article-title":". Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center.","volume":"51","author":"Lasalle-Williams","year":"2011","journal-title":"Transfusion"},{"key":"R10-29-20210209","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/blood-2002-01-0320","article-title":". The DAU allele cluster of the RHD gene.","volume":"100","author":"Wagner","year":"2002","journal-title":"Blood"},{"key":"R12-29-20210209","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1246-7820(96)80004-8","article-title":"Frequency of partial D phenotypes in the south western region of France.","volume":"3","author":"Roubinet","year":"1996","journal-title":"Transfus Clin Biol"},{"key":"R13-29-20210209","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bcmd.2013.11.003","article-title":". Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease.","volume":"52","author":"Reid","year":"2013","journal-title":"Blood Cells Mol Dis"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000000241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:45:52Z","timestamp":1620963952000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201503000-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000241","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}